v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Premiums earned, net (Net of ceded premiums of $91 and $96 for the three months ended June 30, 2026 and 2025 respectively, and $183 and $192 for the six months ended June 30, 2026 and 2025, respectively) $ 737,767 $ 469,826 $ 1,481,956 $ 926,732
Other income 5,400 7,794 10,400 13,219
Total revenues 743,167 477,620 1,492,356 939,951
Operating expenses:        
Net medical claims incurred 590,165 377,992 1,179,813 731,434
Salaries and benefits 54,138 61,309 111,201 120,331
General and administrative expenses 70,299 48,484 144,928 99,159
Depreciation and amortization 564 394 1,079 860
Total operating expenses 715,166 488,179 1,437,021 951,784
Income (loss) from operations 28,001 (10,559) 55,335 (11,833)
Change in fair value of warrants 0 19 0 19
Net income (loss) $ 28,001 $ (10,578) $ 55,335 $ (11,852)
Per share data:        
Basic weighted average number of class A and class B common shares and common share equivalents outstanding (in shares) 524,186,885 509,043,210 523,861,227 508,893,753
Diluted weighted average number of class A and class B common shares and common share equivalents outstanding (in shares) 545,447,735 509,043,210 540,272,301 508,893,753
Basic earnings (loss) per share (in dollars per share) $ 0.05 $ (0.02) $ 0.11 $ (0.02)
Diluted earnings (loss) per share (in dollars per share) $ 0.05 $ (0.02) $ 0.10 $ (0.02)
Net unrealized (loss) gain on available-for-sale investments $ (879) $ 251 $ (2,079) $ 1,761
Comprehensive income (loss) $ 27,122 $ (10,327) $ 53,256 $ (10,091)